Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan r...

書誌詳細
主要な著者:	Larrea, E, Riezu-Boj, J, Gil-Guerrero, L, Casares, N, Aldabe, R, Sarobe, P, Civeira, M, Heeney, J, Rollier, C, Verstrepen, B, Wakita, T, Borrás-Cuesta, F, Lasarte, J, Prieto, J
フォーマット:	Journal article
言語:	English
出版事項:	2007

類似資料

Indoleamine 2,3-dioxygenase in endometriosis
著者:: Hui-Li Yang, 等
出版事項: (2019-01-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
著者:: Lieve Brochez, 等
出版事項: (2021-12-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
著者:: Mona F.M El-Karn, 等
出版事項: (2016-01-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
著者:: Röhrig, U, 等
出版事項: (2010)

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration.
著者:: Chun-Sing Lam, 等
出版事項: (2017-01-01)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
著者:: Aleksandar Acovic, 等
出版事項: (2018-12-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
著者:: Andrew L. Mellor, 等
出版事項: (2017-10-01)

Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
著者:: Asha M. Rudjord-Levann, 等
出版事項: (2023-07-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
著者:: Quan, J, 等
出版事項: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
著者:: Quan, J, 等
出版事項: (2008)

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.
著者:: Kudo, Y, 等
出版事項: (2004)

Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.
著者:: Kudo, Y, 等
出版事項: (2003)

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
著者:: Orabona, C, 等
出版事項: (2018)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
著者:: Chiara Suvieri, 等
出版事項: (2024-11-01)

Research progress of indoleamine 2,3-dioxygenase 1 in gastric cancer
著者:: Pei Xiaxia, 等
出版事項: (2023-03-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
著者:: Camilla Grønkjær Jensen, 等
出版事項: (2021-07-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
著者:: Asim Farooq, 等
出版事項: (2022-09-01)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
著者:: Nao Hirata, 等
出版事項: (2018-09-01)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
著者:: Yuhei Shibata, 等
出版事項: (2016-01-01)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
著者:: Ding Ya, 等
出版事項: (2009-08-01)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
著者:: Tao Zhang, 等
出版事項: (2017-01-01)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
著者:: Lilla Hornyák, 等
出版事項: (2018-01-01)

Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
著者:: Corina Bello, 等
出版事項: (2021-11-01)

Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
著者:: Ning Deng, 等
出版事項: (2021-02-01)

Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts
著者:: Rezakhanlou Alireza, 等
出版事項: (2010-03-01)

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
著者:: Hanako Ohmatsu, 等
出版事項: (2017-02-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
著者:: Christiane A Opitz, 等
出版事項: (2011-01-01)

Indoleamine 2,3 dioxygenase activity aggravates the course and pathology of murine tuberculosis
著者:: Guo, L, 等
出版事項: (2018)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
著者:: V. A. Kozlov, 等
出版事項: (2017-07-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
著者:: Cemil Bilir, M.D., 等
出版事項: (2017-07-01)

Serum indoleamine 2,3-dioxygenase level and diagnostic value in patients with rosacea
著者:: Merve Sena Odabasi, 等
出版事項: (2023-01-01)

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.
著者:: Shamaila Munir, 等
出版事項: (2012-01-01)

Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer
著者:: Anshuman Panda, 等
出版事項: (2021-07-01)

Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
著者:: Lingyan Xu, 等
出版事項: (2021-11-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
著者:: Kuhn, C, 等
出版事項: (2012)

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
著者:: Weirui Li, 等
出版事項: (2021-02-01)

Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi.
著者:: Kudo, Y, 等
出版事項: (2000)

Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.
著者:: Kudo, Y, 等
出版事項: (2001)

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
著者:: Heike Loeser, 等
出版事項: (2020-01-01)

Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study
著者:: Binbin Pan, 等
出版事項: (2021-01-01)